Siemens Healthineers Refocuses Ultrasound Business on Advanced Cardiovascular and Image-Guided Procedures
Siemens Healthineers is refining its ultrasound business strategy to focus more closely on procedural imaging and image-guided therapy, areas that are becoming increasingly important in modern healthcare. The company plans to concentrate its ultrasound portfolio on technologies that help physicians guide minimally invasive procedures, particularly in cardiovascular care. By prioritizing advanced imaging systems, artificial intelligence (AI), software innovation and strategic partnerships, Siemens Healthineers aims to strengthen its position in the evolving cardiovascular intervention market and support the next generation of image-guided treatments.
The strategic shift reflects a broader transformation in medical imaging, where technologies are increasingly being used not only to diagnose diseases but also to guide treatment in real time. As physicians perform more complex procedures, high-quality imaging and immediate visualization can play an important role in supporting clinical decisions, navigating medical instruments and monitoring treatment progress.
Siemens Healthineers intends to build on its existing cardiovascular imaging expertise, including its Acuson Origin cardiovascular imaging platform and its intracardiac echocardiography (ICE) technology. The company will also continue developing software and AI capabilities while expanding collaborations with cardiovascular medical device manufacturers.
Through this focused approach, the company aims to help physicians perform increasingly complex interventions, expand treatment options for patients and prepare for the changing demands of cardiovascular medicine.
Siemens Healthineers Prioritizes Procedural Imaging and Image-Guided Therapy
Medical imaging has traditionally played a central role in identifying diseases, evaluating symptoms and supporting treatment planning. However, technological advances are expanding its role beyond diagnosis. In many clinical settings, imaging is now becoming an essential part of the treatment process itself.
Procedural imaging allows physicians to visualize anatomical structures and medical instruments while performing interventions. This real-time information can help clinicians navigate complex areas of the body and guide procedures that may otherwise require more invasive surgical approaches.
Siemens Healthineers is positioning its ultrasound business to address this growing need. Rather than continuing to compete across the full range of general-purpose ultrasound applications, the company plans to focus its resources on specialized procedural applications, particularly cardiovascular interventions.
The strategy will emphasize four interconnected areas: advanced cardiovascular imaging, intracardiac echocardiography, software and artificial intelligence, and partnerships with cardiovascular device companies.
These areas are closely related to the growing use of minimally invasive techniques in cardiovascular medicine. Electrophysiologists and interventional cardiologists increasingly rely on imaging to guide procedures involving the heart’s internal structures and electrical system.
By concentrating on these applications, Siemens Healthineers aims to deliver technologies designed around the specific requirements of physicians performing image-guided interventions.
The company believes this focus will create opportunities to address unmet clinical needs, develop differentiated solutions and establish long-term value for healthcare providers and patients.
Strengthening Cardiovascular Imaging Capabilities
Cardiovascular disease remains a major global health challenge, creating continued demand for technologies that support earlier diagnosis, effective treatment and improved patient management.
As cardiovascular procedures become more sophisticated, physicians need imaging systems capable of providing detailed anatomical information and supporting complex clinical workflows.
Siemens Healthineers plans to use its Acuson Origin cardiovascular imaging platform as a key component of its procedural imaging strategy. The platform is part of a broader portfolio intended to support physicians working in electrophysiology and structural heart interventions.
Electrophysiology procedures focus on diagnosing and treating abnormal electrical activity in the heart. These procedures may involve identifying the source of irregular heart rhythms and guiding treatment intended to restore or maintain a more normal rhythm.
Structural heart interventions, meanwhile, address problems involving the heart’s valves and other anatomical structures. Depending on the condition, physicians may use catheter-based techniques to repair or treat the affected structures without performing traditional open-heart surgery.
Both types of intervention can require detailed visualization and precise navigation. Imaging technologies can help physicians understand the anatomy, position instruments and monitor procedural progress.
Siemens Healthineers aims to support these requirements through a combination of conventional two-dimensional imaging and more advanced real-time four-dimensional intracardiac echocardiography.
By integrating these capabilities into its procedural ultrasound portfolio, the company intends to support different stages of cardiovascular interventions and help physicians manage increasingly complex procedures.
Advancing Intracardiac Echocardiography Technology
Intracardiac echocardiography is an important element of Siemens Healthineers’ strategy. The technology uses ultrasound imaging from within the heart to provide physicians with detailed views of cardiac structures during selected procedures.
Unlike imaging approaches that obtain views from outside the body, ICE uses specialized catheter-based technology to bring the ultrasound transducer closer to the structures being examined. This can provide useful anatomical information during certain cardiovascular interventions.
ICE can support procedures in which physicians need to visualize the heart’s internal anatomy, assess the position of instruments and monitor relevant structures while treatment is underway.
The technology is particularly relevant to electrophysiology and structural heart procedures, where precise visualization can support procedural planning and execution.
Siemens Healthineers states that it has more than 25 years of innovation in intracardiac echocardiography. The company intends to build on this experience as it develops its procedural imaging portfolio.
Its offerings include established two-dimensional imaging capabilities as well as real-time four-dimensional ICE technology. These solutions are intended to provide physicians with imaging options suited to different procedural requirements.
The continuing development of ICE reflects a broader movement toward more specialized imaging technologies that can be integrated directly into clinical workflows.
As cardiovascular interventions evolve, physicians require imaging systems that can provide useful information without unnecessarily complicating the procedure. Siemens Healthineers is focusing on technologies designed to meet these specialized needs.
The company’s strategy also recognizes that procedural imaging involves more than the imaging system itself. Software, compatible catheters, workflow integration and cooperation with other medical technology companies can all influence how effectively a solution supports clinical practice.
Artificial Intelligence and Software Become Strategic Priorities
Artificial intelligence and advanced software are becoming increasingly important across the medical imaging industry. These technologies can help healthcare professionals process imaging information, improve workflows and access relevant clinical details more efficiently.
Siemens Healthineers plans to make software and AI central elements of its focused ultrasound portfolio.
In procedural settings, imaging systems must provide information that physicians can use while performing treatment. Software capabilities can support image processing, visualization and the integration of imaging information into clinical workflows.
AI may offer additional opportunities to assist with image analysis and reduce the complexity of certain tasks. However, the clinical value of any AI-enabled capability depends on its intended use, performance, validation and integration into the healthcare environment.
By investing in these capabilities, Siemens Healthineers aims to develop procedural imaging solutions that combine hardware with increasingly sophisticated digital tools.
This approach reflects a wider shift in healthcare technology toward integrated platforms rather than standalone equipment. Medical device manufacturers are increasingly considering how imaging hardware, software, data and clinical workflows can work together to support physicians.
For Siemens Healthineers, this integration is particularly relevant to cardiovascular interventions, where clinicians may need to coordinate multiple technologies during a single procedure.
The company also plans to strengthen partnerships with cardiovascular device manufacturers. These collaborations can help align imaging solutions with the requirements of devices used in minimally invasive procedures and support the development of more connected procedural workflows.
Through this combination of imaging, software, AI and partnerships, Siemens Healthineers intends to establish a more specialized and differentiated ultrasound business.
Leadership Emphasizes Imaging’s Expanding Role in Treatment
Sourabh Pagaria, head of Ultrasound at Siemens Healthineers, highlighted the changing role of imaging in modern medicine and the rationale behind the company’s strategic direction.
“Medicine is evolving, and imaging is increasingly becoming part of therapy, not just diagnosis,” Pagaria said.
He explained that concentrating the ultrasound portfolio on procedural imaging will allow the company to apply its strengths in advanced cardiovascular imaging, ICE, software, AI and partnerships with cardiovascular device manufacturers to important clinical needs.
According to Pagaria, the strategy is intended to create long-term value for physicians, patients and Siemens Healthineers.
The comments underscore the company’s view that specialized imaging applications offer opportunities to develop technologies closely aligned with the needs of interventional specialists.
Rather than maintaining a broad presence across multiple general ultrasound applications, Siemens Healthineers plans to focus on areas where its existing capabilities and continued innovation can support a more targeted business strategy.
General Imaging Ultrasound Sales to End for Selected Systems
As part of this transition, Siemens Healthineers announced that, effective October 12, 2026, it would no longer sell its general imaging ultrasound systems, including the Acuson Sequoia, Acuson Redwood, Acuson Juniper and Acuson Maple.
The company will instead concentrate its sales efforts on procedural ultrasound systems and related technologies.
Its procedural portfolio will include the Acuson Origin cardiovascular imaging platform, the P500 ICE system and the Freestyle ultrasound system, together with dedicated software and catheters for procedural customers.
The primary customers for these solutions will include electrophysiologists and interventional cardiologists, whose work frequently involves imaging-guided cardiovascular procedures.
This change represents a significant adjustment to the company’s commercial focus in ultrasound. General imaging ultrasound serves a wide range of clinical applications, while procedural imaging is directed toward more specialized medical settings.
Siemens Healthineers noted that the general imaging ultrasound market continues to be served by multiple established providers. The company is therefore directing its attention toward procedural applications where it sees opportunities to build on its technology portfolio and expertise.
The change in sales strategy does not mean the company will abandon existing customers who use its general imaging systems.
Continued Support for Existing Customers
Siemens Healthineers has stated that it will continue providing service and support for customers who already use its general imaging ultrasound systems.
The company will honor its contractual and regulatory obligations and provide lifecycle support for the installed base. This includes maintenance, software updates and transducer availability.
Maintaining this support is important for healthcare providers that depend on ultrasound equipment for routine clinical services. Hospitals, diagnostic centers and other healthcare organizations often rely on established imaging systems as part of their daily operations.
A change in product sales can create questions about maintenance, replacement parts, software and the continued usability of installed equipment. By committing to ongoing support, Siemens Healthineers aims to provide continuity for existing customers while it redirects its commercial focus.
The distinction between ending new system sales and continuing installed-base support is particularly important for healthcare organizations planning equipment budgets and clinical operations.
Customers will still need to consult the company regarding the specific terms, availability and timing of support applicable to their equipment and service agreements.
Addressing Broader Healthcare Challenges
Siemens Healthineers’ ultrasound strategy forms part of its broader effort to address major health challenges, including cancer, stroke, cardiovascular disease and neurodegenerative conditions.
These diseases place substantial demands on healthcare systems and often require a combination of diagnostic imaging, medical intervention and long-term patient management.
Although the company’s revised ultrasound focus is centered on procedural imaging, the underlying strategy reflects a wider emphasis on technologies that can support clinical decision-making and treatment delivery.
For cardiovascular medicine in particular, advances in minimally invasive procedures are creating new requirements for imaging systems that can operate as part of the intervention itself.
By concentrating on this area, Siemens Healthineers aims to support physicians as treatment techniques evolve and procedural complexity increases.
The company’s approach also illustrates how medical technology manufacturers are making strategic choices about where to invest in research, development and commercial resources.
In a competitive healthcare technology market, specialized solutions that address defined clinical needs may offer opportunities for differentiation. Success will depend on the ability to develop clinically useful technologies, maintain reliable support and establish effective partnerships with healthcare providers and device manufacturers.
A More Focused Future for Ultrasound
Siemens Healthineers’ decision to sharpen its ultrasound business around procedural imaging marks a strategic shift toward specialized cardiovascular applications.
The company plans to combine its Acuson Origin platform, intracardiac echocardiography expertise, software and AI capabilities, and partnerships with cardiovascular device manufacturers to support image-guided interventions.
At the same time, it will discontinue sales of selected general imaging ultrasound systems while continuing to support its existing installed base in accordance with contractual and regulatory obligations.
The long-term opportunity will depend on how effectively Siemens Healthineers translates this focus into technologies that meet physicians’ needs and fit into real-world clinical workflows.
As cardiovascular interventions continue to develop, imaging is expected to remain an important component of procedural planning and execution. Technologies that provide useful real-time visualization and integrate effectively with other medical devices may help physicians navigate increasingly complex procedures.
Through its revised strategy, Siemens Healthineers is positioning its ultrasound business to concentrate on this evolving area of healthcare, with the aim of supporting the next generation of image-guided cardiovascular therapy.
Source link: https://www.siemens-healthineers.com/
